Cardiac Catheterization Patients with atrial fibrillation on oral anticoagulation (oac) undergoing cardiac catheterization face risks for embolic and bleeding events, yet information on strategies to mitigate these risks in contemporary practice is lacking. Conclusions: in a real world registry of patients with atrial fibrillation undergoing cardiac catheterization, most cases are elective, performed by femoral access, with interruption of oac. bleeding avoidance strategies such as radial artery access.
Cardiac Catheterization Ppt In the current meta analysis, catheter based af ablation was associated with decreased risk of all cause mortality, stroke, and hospitalization due to heart failure. however, no significant difference was reported in terms of major bleeding events. keywords: all cause mortality, stroke, meta analysis, atrial fibrillation, catheter ablation. The primary outcome was a composite of hospitalization for atrial fibrillation (af), emergency department visit for af, electrical cardioversion, myocardial infarction, ischemic stroke, major bleeding, and cardiac arrest within 1 year of the index treatment. aad indicates antiarrhythmic drug; ca, catheter ablation. The effect of atrial fibrillation catheter ablation on cardiovascular outcomes in heart failure is an important outstanding research question. we undertook a meta analysis of randomized controlled trials comparing ablation to medical therapy in patients with af and heart failure. Catheter ablation significantly improved rhythm control success compared to medical therapy. subgroup analyses demonstrated variations in outcomes based on patient characteristics, procedural techniques, and follow up durations.
Cardiac Catheterization The effect of atrial fibrillation catheter ablation on cardiovascular outcomes in heart failure is an important outstanding research question. we undertook a meta analysis of randomized controlled trials comparing ablation to medical therapy in patients with af and heart failure. Catheter ablation significantly improved rhythm control success compared to medical therapy. subgroup analyses demonstrated variations in outcomes based on patient characteristics, procedural techniques, and follow up durations. Patients who undergo catheter ablation for atrial fibrillation (afib) who also have heart failure with preserved ejection fraction (hfpef) experienced a greater benefit from ablation in terms of clinical outcome, afib recurrence and functional status, according to findings from the cabana trial published april 16 in jacc: heart failure.another recent retrospective study in patients with heart. Use of bleeding avoidance strategies and bridging therapy were described and outcomes including death, stroke, and major bleeding at 30 days and 1 year were compared by oac type. We systematically identified all trials comparing catheter ablation to medical therapy in patients with heart failure and atrial fibrillation. the pre specified primary endpoint was all cause mortality in trials with at least 2 years of follow up. the secondary endpoint was heart failure hospitalization. Evidence suggests catheter ablation improves outcomes in cm patients, though success is influenced by the extent of atrial and ventricular remodeling. patients undergoing their first catheter ablation for af were divided into hypertrophic (hcm), ischemic (icm), non ischemic (nicm), and no cm groups.
Cardiac Catheterization Results In Patients Who Were Chosen For Patients who undergo catheter ablation for atrial fibrillation (afib) who also have heart failure with preserved ejection fraction (hfpef) experienced a greater benefit from ablation in terms of clinical outcome, afib recurrence and functional status, according to findings from the cabana trial published april 16 in jacc: heart failure.another recent retrospective study in patients with heart. Use of bleeding avoidance strategies and bridging therapy were described and outcomes including death, stroke, and major bleeding at 30 days and 1 year were compared by oac type. We systematically identified all trials comparing catheter ablation to medical therapy in patients with heart failure and atrial fibrillation. the pre specified primary endpoint was all cause mortality in trials with at least 2 years of follow up. the secondary endpoint was heart failure hospitalization. Evidence suggests catheter ablation improves outcomes in cm patients, though success is influenced by the extent of atrial and ventricular remodeling. patients undergoing their first catheter ablation for af were divided into hypertrophic (hcm), ischemic (icm), non ischemic (nicm), and no cm groups.
Cardiac Catheterization Ppt We systematically identified all trials comparing catheter ablation to medical therapy in patients with heart failure and atrial fibrillation. the pre specified primary endpoint was all cause mortality in trials with at least 2 years of follow up. the secondary endpoint was heart failure hospitalization. Evidence suggests catheter ablation improves outcomes in cm patients, though success is influenced by the extent of atrial and ventricular remodeling. patients undergoing their first catheter ablation for af were divided into hypertrophic (hcm), ischemic (icm), non ischemic (nicm), and no cm groups.
Comments are closed.